A Forrester Total Economic Impact™ Study Commissioned By Rhapsody, July 2024
Healthcare data integration solutions have become increasingly crucial for organizations operating in the dynamic healthcare landscape. As healthcare delivery systems digitize their processes and generate data, seamless communication between disparate points of service is essential. The digital health enablement platform from Rhapsody includes health data integration solutions that not only streamline data flow and but position organizations to thrive in a data-driven, patient-centric healthcare ecosystem.
Rhapsody is a healthcare solution software developer. Its digital health enablement solutions offer services and tools to securely integrate and accurately identify health data across systems, accelerating digital innovation. It enables healthcare teams to achieve data interoperability, which is crucial for seamless communication and efficient workflows in the healthcare ecosystem. By addressing data connectivity and quality challenges, Rhapsody helps organizations innovate, realize revenue faster, and optimize resource productivity. Rhapsody commissioned Forrester Consulting to conduct a Total Economic Impact™ (TEI) study and examine the potential return on investment (ROI) enterprises may realize by deploying Rhapsody Digital Health Enablement Solutions.1 The purpose of this study is to provide readers with a framework to evaluate the potential financial impact of Rhapsody on their organizations.
To better understand the benefits, costs, and risks associated with this investment, Forrester interviewed four representatives with experience using Rhapsody. For the purposes of this study, Forrester aggregated the health system IDN and health technology vendor interviewees’ experiences and combined the results into a single composite organization, a US-based health technology organization that generates $25 million in revenue annually across global operations. Readers can apply the TEI data to their own organization by extrapolating the benefits and investments of the composite organization. By using these methods, health system readers can tailor the insights from the TEI study to better reflect their unique financial and operational contexts.
Interviewees said that prior to using Rhapsody, their organizations leveraged a mixture of point, homegrown, and customized integration solutions. Prior efforts led to a variety of challenges, including high complexity and operational overhead to manage an unstructured approach to connecting patient data, a lack of expertise across internal integration engineering teams, and further time-consuming efforts to create and manage application integrations.
After investing in Rhapsody, the interviewees streamlined their integration capabilities, including electronic health record (EHR) connectivity, onto a single platform; this resulted in improved integration engineering and analyst efficiency, faster time to market, new revenue opportunities, and reduced integration engineer ramp-up time.
Quantified benefits. Three-year, risk-adjusted present value (PV) quantified benefits for the composite organization include:
Unquantified benefits. Benefits that provide value for the composite organization but are not quantified for this study include:
Costs. Three-year, risk-adjusted PV costs for the composite organization include:
The representative interviews and financial analysis found that a composite organization experiences benefits of $2.42 million over three years versus costs of $828,000, adding up to a net present value (NPV) of $1.59 million and an ROI of 193%.
Return on investment (ROI)
Benefits PV
Net present value (NPV)
Payback
From the information provided in the interviews, Forrester constructed a Total Economic Impact™ framework for those organizations considering an investment in Rhapsody.
The objective of the framework is to identify the cost, benefit, flexibility, and risk factors that affect the investment decision. Forrester took a multistep approach to evaluate the impact that Rhapsody can have on an organization.
Interviewed Rhapsody stakeholders and Forrester analysts to gather data relative to Rhapsody.
Interviewed four representatives at organizations using Rhapsody to obtain data about costs, benefits, and risks.
Designed a composite organization based on characteristics of the interviewees’ organizations.
Constructed a financial model representative of the interviews using the TEI methodology and risk-adjusted the financial model based on issues and concerns of the interviewees.
Employed four fundamental elements of TEI in modeling the investment impact: benefits, costs, flexibility, and risks. Given the increasing sophistication of ROI analyses related to IT investments, Forrester’s TEI methodology provides a complete picture of the total economic impact of purchase decisions. Please see Appendix A for additional information on the TEI methodology.
Readers should be aware of the following:
This study is commissioned by Rhapsody and delivered by Forrester Consulting. It is not meant to be used as a competitive analysis.
Forrester makes no assumptions as to the potential ROI that other organizations will receive. Forrester strongly advises that readers use their own estimates within the framework provided in the study to determine the appropriateness of an investment in Rhapsody.
Rhapsody reviewed and provided feedback to Forrester, but Forrester maintains editorial control over the study and its findings and does not accept changes to the study that contradict Forrester’s findings or obscure the meaning of the study.
Rhapsody provided the customer names for the interviews but did not participate in the interviews.
Consulting Team:
Rachel Ballard
Luca Son
| Role | Type Of Organization | Region | Number Of Employees |
|---|---|---|---|
| Associate VP of applications and interoperability | Healthcare provider, integrated delivery network (IDN) | US | 25,000+ |
| Chief technical architect | Health technology, specializing in medical device software and hardware | US with global operations | 20,000+ |
| Chief information officer | Health technology, specializing in AI surgical platforms | US with global operations | 200+ |
| Integration contractor | Health technology, specializing in patient engagement software development | US | 50+ |
Prior to Rhapsody, interviewees used several other middleware point solutions, which were typically customized and homegrown; they varied due to acquisitions or team preferences. The interviewees noted how their organizations struggled with common challenges, including:
The interviewees’ organizations searched for a solution that could offer:
The interviewees’ organizations searched for a solution that could:
Based on the interviews, Forrester constructed a TEI framework, a composite company, and an ROI analysis that illustrates the areas financially affected. The composite organization is representative of the four interviewees, and it is used to present the aggregate financial analysis in the next section. The composite organization has the following characteristics:
Description of composite. The US-based health technology composite organization generates $25 million in recurring revenue annually across global operations. Prior to Rhapsody, the composite relied on several homegrown custom integration point solutions. The composite organization employs two integration engineers.
Deployment characteristics. The composite organization replaces its point solutions with Rhapsody, beginning with one integration in the initial rollout and scaling the number of patient data connections to 15 per year for the following three years.
| Ref. | Benefit | Year 1 | Year 2 | Year 3 | Total | Present Value |
|---|---|---|---|---|---|---|
| Atr | Avoided integration engineering and analyst hires | $421,200 | $421,200 | $421,200 | $1,263,600 | $1,047,462 |
| Btr | Improved time to market | $320,625 | $320,625 | $320,625 | $961,875 | $797,347 |
| Ctr | Business acceleration and incremental net operating revenue attributed to improved deployment experience | $135,000 | $135,000 | $135,000 | $405,000 | $335,725 |
| Dtr | Improved engineer and analyst efficiency | $97,171 | $97,171 | $97,171 | $291,514 | $241,650 |
| Total benefits (risk-adjusted) | $973,996 | $973,996 | $973,996 | $2,921,989 | $2,422,184 | |
Evidence and data. Interviewees told Forrester that Rhapsody streamlined interface development with its low-code to code-free integration solution. Prior environments before Rhapsody were siloed, lacked standardization, and resulted in additional and duplicative work for engineers. With Rhapsody, integration developers and analysts benefited from intuitive tools, standardized protocols, scripting components, and scalability, reducing development time compared to manual integrations. Overall, Rhapsody empowered engineers to work efficiently, focus their time on strategic tasks, and achieve better outcomes.
Modeling and assumptions. Based on the interviews, Forrester assumes the following about the composite organization:
Risks. Forrester recognizes that these results may not be representative of all experiences. The impact of this benefit will vary depending on:
Results. To account for these risks, Forrester adjusted this benefit downward by 10%, yielding a three-year, risk-adjusted total PV (discounted at 10%) of $1.0 million.
| Ref. | Metric | Source | Year 1 | Year 2 | Year 3 |
|---|---|---|---|---|---|
| A1 | Number of engineers that would be required to map, integrate, and deploy healthcare data without Rhapsody | Interviews | 4 | 4 | 4 |
| A2 | Fully burdened annual salary for an integration engineer | TEI standard | $117,000 | $117,000 | $117,000 |
| At | Avoided integration engineering and analyst hires | A1*A2 | $468,000 | $468,000 | $468,000 |
| Risk adjustment | ↓10% | ||||
| Atr | Avoided integration engineering and analyst hires (risk-adjusted) | $421,200 | $421,200 | $421,200 | |
| Three-year total: $1,263,600 | Three-year present value: $1,047,462 | ||||
Evidence and data. Interviewees told Forrester that Rhapsody improved their time to market compared to prior integration methods. Rhapsody tools streamlined the integration creation and configuration process, allowing for quicker system integrations. Efficient data exchange ensured adequate communication between applications, leading to faster development and deployment cycles. Rhapsody’s expertise and customer success team also helped interviewees’ organizations focus on core development while leveraging proven technology and achieving faster time to revenue. Integrations built with Rhapsody better ensured data quality during migration, leading to faster project delivery.
Modeling and assumptions. Based on the interviews, Forrester assumes the following about the composite organization:
Risks. Forrester recognizes that these results may not be representative of all experiences. The impact of this benefit will vary depending on:
Results. To account for these risks, Forrester adjusted this benefit downward by 10%, yielding a three-year, risk-adjusted total PV (discounted at 10%) of $797,000.
| Ref. | Metric | Source | Year 1 | Year 2 | Year 3 | |
|---|---|---|---|---|---|---|
| B1 | Total annual revenue less new revenue attributed to improved deployment experience | Composite | $23,750,000 | $23,750,000 | $23,750,000 | |
| B2 | Revenue per day less new revenue attributed to improved deployment experience | B1/360 days | $65,972 | $65,972 | $65,972 | |
| B3 | Time to market improvement (days) | Interviews | 30 | 30 | 30 | |
| B4 | Number of patient data connections per year | Composite | 15 | 15 | 15 | |
| B5 | Percentage gain due to time to market improvement | Assumption | 10% | 10% | 10% | |
| B6 | Operating profit margin | Composite | 12% | 12% | 12% | |
| Bt | Improved time to market | B2*B3*B4*B5*B6 | $356,250 | $356,250 | $356,250 | |
| Risk adjustment | ↓10% | |||||
| Btr | Improved time to market (risk-adjusted) | $320,625 | $320,625 | $320,625 | ||
| Three-year total: $961,875 | Three-year present value: $797,347 | |||||
Evidence and data. Interviewees said Rhapsody enhanced data exchange, streamlined integration processes, ensured higher accuracy, and sped up time to value. Their organizations enhanced the deployment experience for customers and, in turn, generated greater net revenue. One interviewee leveraged Rhapsody to accelerate customer integration timelines and improve the customer onboarding experience. The chief technical architect at a healthcare technology software development organization said: “[Rhapsody] has improved the bottom-line financials for sure because it’s an incredibly important part of the solution.” Separately, an integration contractor at a health technology organization told Forrester, “As an estimate, our revenue increased 10%, and that’s because of integration.”
Modeling and assumptions. Based on the interviews, Forrester assumes the following about the composite organization:
Risks. Forrester recognizes that these results may not be representative of all experiences. The impact of this benefit will vary depending on:
Results. To account for these risks, Forrester adjusted this benefit downward by 10%, yielding a three-year, risk-adjusted total PV (discounted at 10%) of $336,000.
| Ref. | Metric | Source | Year 1 | Year 2 | Year 3 | |
|---|---|---|---|---|---|---|
| C1 | Total annual revenue | Composite | $25,000,000 | $25,000,000 | $25,000,000 | |
| C2 | Percent revenue attributed to improved deployment experience | Composite | 5% | 5% | 5% | |
| C3 | Net operating profit margin | Composite | 12% | 12% | 12% | |
| Ct | Business acceleration and incremental net operating revenue attributed to improved deployment experience | C1*C2*C3 | $150,000 | $150,000 | $150,000 | |
| Risk adjustment | ↓10% | |||||
| Ctr | Business acceleration and incremental net operating revenue attributed to improved deployment experience (risk adjusted) | $135,000 | $135,000 | $135,000 | ||
| Three-year total: $405,000 | Three-year present value: $335,725 | |||||
Evidence and data. Interviewees told Forrester that Rhapsody enhanced integration efficiency by minimizing the overhead required for post-deployment integration adjustments and improving the speed to ramp up new engineers. Prior integration tools and methods were disjointed, leading to human-capital-intensive issues. By centralizing integration capabilities onto Rhapsody, interviewees’ organizations avoided post-deployment intervention costs altogether. Rhapsody’s reliability and high-availability features enhanced the continuity of performance in interviewees’ complex healthcare environments. An integration contractor at a health technology firm told Forrester: “All the alerts are coming as soon as possible. We can easily monitor if something went wrong, and we need to step in. It’s gone from a few hours to 15 minutes.”
Separately, interviewees found that Rhapsody streamlined the time to ramp up new engineers. The integration contractor at a health technology organization said: “It’s much easier to hire a new employee [with Rhapsody]. We have trainings based on our solutions and framework that we built, and we can propose all of this to our newcomer, and it gets much easier because it’s logical, it’s structured, it’s well organized.” The same interviewee continued: “All people are working within the same tool; if there is one person not present today or on vacation and there is an ongoing project, it’s much easier for another person to step in and handle the situation. We have a rotation within the team that everyone should be able to read the configuration, as it’s pretty standard. That wouldn’t be possible with our old platforms where everything was customized.”
Modeling and assumptions. Based on the interviews, Forrester assumes the following about the composite organization:
Risks. Forrester recognizes that these results may not be representative of all experiences. The impact of this benefit will vary depending on:
Results. To account for these risks, Forrester adjusted this benefit downward by 10%, yielding a three-year, risk-adjusted total PV (discounted at 10%) of $242,000.
| Ref. | Metric | Source | Year 1 | Year 2 | Year 3 |
|---|---|---|---|---|---|
| D1 | Number of disruptions per week requiring intervention | Composite | 7 | 7 | 7 |
| D2 | Time required per disruption requiring intervention in the legacy environment (hours) | Interviews | 8 | 8 | 8 |
| D3 | Time required per disruption requiring intervention post-deployment (hours) | Interviews | 3 | 3 | 3 |
| D4 | Fully burdened hourly rate for an integration engineer | A2/2,080 | $56 | $56 | $56 |
| D5 | Subtotal: Integration team efficiencies gained due to the reduction in disruptions requiring intervention | (D1*52)*(D2-D3)*D4 | $101,920 | $101,920 | $101,920 |
| D6 | Number of integration engineer replacements required per month | Interviews | 1 | 1 | 1 |
| D7 | Time required to ramp up on an existing integration prior to adopting Rhapsody (hours) | Interviews | 12 | 12 | 12 |
| D8 | Time required to ramp up on an existing integration post-deployment (hours) | Interviews | 3 | 3 | 3 |
| D9 | Fully burdened hourly rate for an integration engineer | D4 | $56 | $56 | $56 |
| D10 | Subtotal: Time saved ramping up a replacement integration engineer on an existing integration | (D6*12)*(D7-D8)*D9 | $6,048 | $6,048 | $6,048 |
| Dt | Improved engineer and analyst efficiency | D5+D10 | $107,968 | $107,968 | $107,968 |
| Risk adjustment | ↓10% | ||||
| Dtr | Improved engineer and analyst efficiency (risk-adjusted) | $97,171 | $97,171 | $97,171 | |
| Three-year total: $291,514 | Three-year present value: $241,650 | ||||
Interviewees mentioned the following additional benefits that their organizations experienced but were not able to quantify:
The value of flexibility is unique to each customer. There are multiple scenarios in which a customer might implement Rhapsody and later realize additional uses and business opportunities, including:
Flexibility would also be quantified when evaluated as part of a specific project (described in more detail in Appendix A).
| Ref. | Cost | Initial | Year 1 | Year 2 | Year 3 | Total | Present Value |
|---|---|---|---|---|---|---|---|
| Etr | Total fees to Rhapsody | $0 | $159,500 | $159,500 | $159,500 | $478,500 | $396,653 |
| Ftr | Initial and ongoing costs | $22,176 | $165,088 | $165,088 | $162,624 | $514,976 | $430,874 |
| Total costs (risk-adjusted) | $22,176 | $324,588 | $324,588 | $322,124 | $993,476 | $827,527 | |
Evidence and data. Interviewees paid an annual subscription fee and platform fee to Rhapsody. Pricing varied based on factors like organization size, size and number of data connections, licensing agreements, and additional features.
Modeling and assumptions. Based on the interviews, Forrester assumes the following about the composite organization:
Risks. Forrester recognizes that these results may not be representative of all experiences. The impact of this benefit will vary depending on:
Results. To account for these risks, Forrester adjusted this cost upward by 10%, yielding a three-year, risk-adjusted total PV (discounted at 10%) of $397,000.
| Ref. | Metric | Source | Initial | Year 1 | Year 2 | Year 3 | |
|---|---|---|---|---|---|---|---|
| E1 | Annual implementation fee for 15 patient data connections | Interviews | $100,000 | $100,000 | $100,000 | ||
| E2 | Annual platform fee | Interviews | $45,000 | $45,000 | $45,000 | ||
| Et | Total fees to Rhapsody | E1+E2 | $145,000 | $145,000 | $145,000 | ||
| Risk adjustment | ↑10% | ||||||
| Etr | Total fees to Rhapsody (risk-adjusted) | $159,500 | $159,500 | $159,500 | |||
| Three-year total: $478,500 | Three-year present value: $396,653 | ||||||
Evidence and data. Interviewees incurred initial and ongoing costs on top of their fees to Rhapsody. This typically included upfront and ongoing labor to create and manage patient data connections and initial and ongoing training for integration engineers.
Modeling and assumptions. Based on the interviews, Forrester assumes the following about the composite organization:
Risks. Forrester recognizes that these results may not be representative of all experiences. The impact of this benefit will vary depending on:
Results. To account for these risks, Forrester adjusted this cost upward by 10%, yielding a three-year, risk-adjusted total PV (discounted at 10%) of $431,000.
| Ref. | Metric | Source | Initial | Year 1 | Year 2 | Year 3 | |
|---|---|---|---|---|---|---|---|
| F1 | Number of patient data connections per year | Composite | 1 | 15 | 15 | 15 | |
| F2 | Number of internal integration engineer FTEs required per patient data connection | Interviews | 2 | 1 | 1 | 1 | |
| F3 | Internal time required per patient data connection (hours) | Interviews | 160 | 160 | 160 | 160 | |
| F4 | Fully burdened hourly rate for an integration engineer | A2/2,080 hours | $56 | $56 | $56 | $56 | |
| F5 | Subtotal: Internal implementation costs | F1*F2*F3*F4 | $17,920 | $134,400 | $134,400 | $134,400 | |
| F6 | Initial and ongoing training | 20 hours/year per integration engineer*F4 | $2,240 | $2,240 | $2,240 | $2,240 | |
| F7 | Ongoing management | 20 hours/month* 12 months*F4 | $13,440 | $13,440 | $13,440 | ||
| Ft | Initial and ongoing costs | F5+F6+F7 | $20,160 | $150,080 | $150,080 | $147,840 | |
| Risk adjustment | ↑10% | ||||||
| Ftr | Initial and ongoing costs (risk-adjusted) | $22,176 | $165,088 | $165,088 | $162,624 | ||
| Three-year total: $514,976 | Three-year present value: $430,874 | ||||||
The financial results calculated in the Benefits and Costs sections can be used to determine the ROI, NPV, and payback period for the composite organization’s investment. Forrester assumes a yearly discount rate of 10% for this analysis.
These risk-adjusted ROI, NPV, and payback period values are determined by applying risk-adjustment factors to the unadjusted results in each Benefit and Cost section.
| Initial | Year 1 | Year 2 | Year 3 | Total | Present Value | |
|---|---|---|---|---|---|---|
| Total costs | ($22,176) | ($324,588) | ($324,588) | ($322,124) | ($993,476) | ($827,527) |
| Total benefits | $0 | $973,996 | $973,996 | $973,996 | $2,921,989 | $2,422,184 |
| Net benefits | ($22,176) | $649,408 | $649,408 | $651,872 | $1,928,513 | $1,594,657 |
| ROI | 193% | |||||
| Payback | <6 months | |||||
Total Economic Impact is a methodology developed by Forrester Research that enhances a company’s technology decision-making processes and assists vendors in communicating the value proposition of their products and services to clients. The TEI methodology helps companies demonstrate, justify, and realize the tangible value of IT initiatives to both senior management and other key business stakeholders.
Benefits represent the value delivered to the business by the product. The TEI methodology places equal weight on the measure of benefits and the measure of costs, allowing for a full examination of the effect of the technology on the entire organization.
Costs consider all expenses necessary to deliver the proposed value, or benefits, of the product. The cost category within TEI captures incremental costs over the existing environment for ongoing costs associated with the solution.
Flexibility represents the strategic value that can be obtained for some future additional investment building on top of the initial investment already made. Having the ability to capture that benefit has a PV that can be estimated.
Risks measure the uncertainty of benefit and cost estimates given: 1) the likelihood that estimates will meet original projections and 2) the likelihood that estimates will be tracked over time. TEI risk factors are based on “triangular distribution.”
The initial investment column contains costs incurred at “time 0” or at the beginning of Year 1 that are not discounted. All other cash flows are discounted using the discount rate at the end of the year. PV calculations are calculated for each total cost and benefit estimate. NPV calculations in the summary tables are the sum of the initial investment and the discounted cash flows in each year. Sums and present value calculations of the Total Benefits, Total Costs, and Cash Flow tables may not exactly add up, as some rounding may occur.
Related Forrester Research
Why CX For Healthcare: Proof That Investing In Experience Improves Revenue, Cost, And Resilience, Forrester Research, Inc., April 8, 2023.
The Future Of Healthcare: Success In 2030 Hinges On Customer Obsession And Agility, Forrester Research, Inc., February 1, 2024.
1 Total Economic Impact is a methodology developed by Forrester Research that enhances a company’s technology decision-making processes and assists vendors in communicating the value proposition of their products and services to clients. The TEI methodology helps companies demonstrate, justify, and realize the tangible value of IT initiatives to both senior management and other key business stakeholders.
Cookie Preferences
Accept Cookies
A cookie is a small text file that a website saves on your computer or mobile device when you visit the site. It enables the website to remember your actions (data inputs, website navigation), so you don’t have to re-enter data when you come back to the site or browse from one page to another.
Behavioral information collected by our web analytics vendor is used to analyze data pertaining to visitor trends, plan website enhancements, and measure overall website effectiveness. We may also use cookies or web beacons to help us offer you products, programs, or services that may be of interest to you and to deliver relevant advertising. We may use third-party advertising companies to help tailor website content to users or to serve ads on our behalf. These companies may also employ cookies and web beacons to measure advertising effectiveness.
Please accept cookies and the collection of behavioral information to receive full functionality and enhance your experience. If you decline cookies, some features of the website may not function normally.
Please see our
Privacy Policy for more information.